Industry Overview
India’s pharmaceutical industry is one of the largest in the world by volume, encompassing drug manufacturing, formulation, active pharmaceutical ingredient (API) production, contract research and manufacturing, and a rapidly expanding export footprint. Pharma companies operate under one of the most tightly regulated frameworks in the country, where every stage from drug development through manufacturing, pricing, and marketing carries distinct compliance obligations.
Whether a company is engaged in generic drug manufacturing, clinical research, or the marketing and distribution of formulations, legal risk touches licensing, quality control, pricing regulation, and intellectual property at every stage. This makes specialised regulatory and transactional counsel essential for pharma businesses looking to scale domestically and internationally.
Legal & Regulatory Landscape
Pharmaceutical businesses in India are governed primarily by the Drugs and Cosmetics Act and the New Drugs and Clinical Trials Rules, which set out manufacturing licensing, quality standards, and clinical trial approval requirements enforced by the Central Drugs Standard Control Organisation (CDSCO) and state drug licensing authorities. Good Manufacturing Practice (GMP) compliance, product registration, and labelling requirements apply across the manufacturing and marketing lifecycle.
Pricing is separately regulated under the Drugs (Prices Control) Order, while patent protection and freedom-to-operate analysis are critical given the long development timelines typical of pharma innovation. Companies must also navigate pharmacovigilance obligations, import-export licensing, and distribution and marketing agreements with hospitals, pharmacies, and international partners each carrying its own compliance and disclosure requirements.
How We Help
We advise pharmaceutical manufacturers, formulators, and distributors on obtaining and maintaining manufacturing licences, CDSCO approvals, and GMP compliance, and we support clinical trial approvals and regulatory submissions. Our team drafts and negotiates manufacturing, distribution, and marketing agreements, ensuring clear terms on quality obligations, liability, and territory.
We also advise on drug pricing compliance under the DPCO, protect pharma innovations through patent strategy and IP enforcement, and support import-export compliance for active ingredients and finished formulations. Where disputes arise with regulators, partners, or distributors, we represent our pharma clients through negotiation and, where necessary, litigation helping our clients bring products to market while managing regulatory risk at every stage.
Client SpotlightWe are proud to advise Bo International, a private-label cosmetics and skincare manufacturer that formulates and produces for international beauty brands across the UK and USA, on regulatory compliance, contract manufacturing agreements, and IP protection. We also support Eona BioLabs on regulatory compliance, IP protection, and research and licensing agreements, and advise Mannat Wellness Clinic, a Gurugram-based provider of PRP tubes and sterile examination gloves, on regulatory and supply-related legal matters. |